RxDoctor Payments Data

Gabriella Acosta, APRN

Gerontology · Tampa, FLNPI 1336758788

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,997 of the $5,166 with a category attached, or 77.4%. 15 manufacturers reported payments, led by Sanofi at 39.4% of the total. Reporting peaked in 2024 at $2,687 and has fallen 73.7% since, to $707 in 2025. Among gerontology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,166in general payments, 2019–2025

Across 43 payments — averaging $120.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$2K
  • Johnson & Johnson$928
  • GSK$464
  • Genmab U.S., Inc.$292
  • Takeda Pharmaceuticals U.S.A., Inc.$271
  • Legend Biotech USA Inc.$209
  • plus $969 from 9 others

What the payments were for

  • Consulting fees$1,16923%
  • Food & beverage$3,99777%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,166 in reported general payments places this provider in the 90th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$45,577
Medicare patients
265
Services billed
605

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acyclovir84$1,175
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim24$465
Gabapentin25$199
Dexamethasone13$181
Potassium Chloride18$133
Ondansetron Hcl19$128
Famotidine11$39

Paid to pharmacies, not to this prescriber.

Other gerontology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →